Shelter Pharma Secures ₹27,540 Order from Sudan Partner for D3 Cure Capsules
Shelter Pharma Limited announced securing another international order worth ₹27,540 from Sudan-based Taha Drugs & Chemicals Co. Ltd for D3 Cure Capsules. This represents the third order from the same client, following previous orders worth ₹98,875 and ₹27,600, demonstrating continued business expansion in international markets with execution timeline of 2 months.

*this image is generated using AI for illustrative purposes only.
Shelter Pharma Limited , a pharmaceutical and nutraceutical company, has announced securing another international order from Taha Drugs & Chemicals Co. Ltd, a Sudan-based entity. The latest order is worth ₹27,540 for D3 Cure Capsules, adding to the company's growing international business portfolio.
Latest Order Details
The recent order announcement provides the following specifications:
| Aspect: | Details |
|---|---|
| Product: | D3 Cure Capsules |
| Order Value: | ₹27,540 |
| Execution Timeline: | Within 2 months |
| Client Location: | Sudan (International entity) |
| Related Party Transaction: | No |
Previous Order History
This marks the third order from the same Sudan-based client, demonstrating a continued business relationship with the international partner. The company has previously secured orders including one worth ₹98,875 for Joemega Capsules and Vitamin Tablets, and another worth ₹27,600 for Joemega Capsules.
| Order Comparison: | Previous Orders | Latest Order |
|---|---|---|
| Order Values: | ₹98,875 & ₹27,600 | ₹27,540 |
| Products: | Joemega Capsules & Vitamin Tablets | D3 Cure Capsules |
| Timeline: | Within 2 months | Within 2 months |
Regulatory Compliance
Shelter Pharma Limited has confirmed that this latest order does not constitute a related party transaction. The company's promoters have no interest in Taha Drugs & Chemicals Co. Ltd, ensuring transparency in operations and compliance with regulatory requirements under SEBI regulations.
Company Profile
Shelter Pharma Limited positions itself as a leading pharmaceutical and nutraceutical company dedicated to research, innovation, and quality healthcare solutions. The company operates state-of-the-art facilities and maintains a commitment to ethical practices, focusing on producing safe and effective products that enhance quality of life globally.
These consecutive orders from the Sudan-based partner indicate strengthening international relationships and demonstrate the company's ability to secure diverse product orders across different therapeutic segments, which may contribute positively to the company's financial performance.
Historical Stock Returns for Shelter Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.06% | -4.73% | -3.69% | -15.85% | -44.56% | -15.99% |
































